AU2003292347A1 - Methods for screening compounds modulating cholesterol flux and uses thereof - Google Patents

Methods for screening compounds modulating cholesterol flux and uses thereof

Info

Publication number: AU2003292347A1
Authority: AU; Australia
Prior art keywords: methods; screening compounds; compounds modulating; modulating cholesterol; cholesterol flux
Prior art date: 2002-11-15
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2003292347A

Other languages

English (en)

Inventor

Guilhem Larigauderie

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Genfit SA

Original Assignee

Genfit SA

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-11-15

Filing date

2003-11-05

Publication date

2004-06-15

2003-11-05 Application filed by Genfit SA filed Critical Genfit SA

2004-06-15 Publication of AU2003292347A1 publication Critical patent/AU2003292347A1/en

Status Abandoned legal-status Critical Current

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Chemical & Material Sciences (AREA)
Hematology (AREA)
Molecular Biology (AREA)
Urology & Nephrology (AREA)
Biomedical Technology (AREA)
General Health & Medical Sciences (AREA)
Immunology (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Pathology (AREA)
Chemical Kinetics & Catalysis (AREA)
Microbiology (AREA)
Physics & Mathematics (AREA)
Analytical Chemistry (AREA)
Biochemistry (AREA)
Cell Biology (AREA)
General Physics & Mathematics (AREA)
Biotechnology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Food Science & Technology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Vascular Medicine (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biophysics (AREA)
Endocrinology (AREA)
Diabetes (AREA)
Obesity (AREA)
Investigating Or Analysing Biological Materials (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

AU2003292347A 2002-11-15 2003-11-05 Methods for screening compounds modulating cholesterol flux and uses thereof Abandoned AU2003292347A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
FR0214345A FR2847266A1 (fr)	2002-11-15	2002-11-15	Methodes de criblage de composes modulant le flux de cholesterol et utilisations
FR02/14345		2002-11-15
PCT/FR2003/003303 WO2004046732A1 (fr)	2002-11-15	2003-11-05	Methodes de criblage de composes modulant le flux de cholesterol et utilisations

Publications (1)

Publication Number	Publication Date
AU2003292347A1 true AU2003292347A1 (en)	2004-06-15

Family

ID=32187650

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2003292347A Abandoned AU2003292347A1 (en)	2002-11-15	2003-11-05	Methods for screening compounds modulating cholesterol flux and uses thereof

Country Status (3)

Country	Link
AU (1)	AU2003292347A1 (fr)
FR (1)	FR2847266A1 (fr)
WO (1)	WO2004046732A1 (fr)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6261760B1 (en) *	1998-03-09	2001-07-17	The Regents Of The University Of California	Regulation of the cell cycle by sterols
AU784108B2 (en) *	1999-03-15	2006-02-02	University Of British Columbia, The	Methods and reagents for modulating cholesterol levels
AU1683801A (en) *	1999-11-16	2001-05-30	Hamilton Civic Hospitals Research Development, Inc.	Methods and compositions for modulating er-stress-induced cholesterol/triglyceride accumulation

2002
- 2002-11-15 FR FR0214345A patent/FR2847266A1/fr active Pending
2003
- 2003-11-05 AU AU2003292347A patent/AU2003292347A1/en not_active Abandoned
- 2003-11-05 WO PCT/FR2003/003303 patent/WO2004046732A1/fr not_active Ceased

Also Published As

Publication number	Publication date
WO2004046732A8 (fr)	2005-04-07
WO2004046732A1 (fr)	2004-06-03
FR2847266A1 (fr)	2004-05-21

Similar Documents

Publication	Publication Date	Title
AU2003281427A1 (en)	2004-01-23	Advertising trays for security screening
AU2003226094A1 (en)	2003-10-13	Compounds and methods
AU2003216337A1 (en)	2003-09-16	Firewall
AU2003268387A1 (en)	2004-04-08	Apparatus and method for releaseably joining elements
AU2002300087A1 (en)	2003-06-12	Method and Device for Joining Screens
AU2003281452A1 (en)	2004-01-23	Method and apparatus for layered modulation
AU2003258454A1 (en)	2004-04-30	Compounds for modulating the glycolosis enzyme complex and/or transaminase complex
AU2003277663A1 (en)	2004-06-03	Screening method
AU2002249467A1 (en)	2002-11-18	Screening method
AU2003268670A1 (en)	2004-04-19	Joining apparatus
AU2003242340A1 (en)	2003-12-31	Novel screening method
AU2002364612A1 (en)	2003-07-24	METHODS AND MATERIALS FOR MODULATING ENaC-BETA
AU2003263129A1 (en)	2004-03-19	Laser-supported reproduction method
AU2002247215A1 (en)	2002-09-04	Method for screening compounds
AU2002234729A1 (en)	2003-02-13	Method for identifying compounds modulating reverse cholesterol transport
AU2003292347A1 (en)	2004-06-15	Methods for screening compounds modulating cholesterol flux and uses thereof
AU2003227268A1 (en)	2003-10-13	Novel screening method
AU2003251156A1 (en)	2004-01-23	Screening for anti-ovulatory compounds
AU2002952966A0 (en)	2002-12-12	Screening apparatus
AU2002348807A1 (en)	2003-05-15	Screening method which uses BNPI and DNPI
AU2002317093A1 (en)	2003-01-21	Screening processes for agents modulating cholesterol levels
AU2002354247A1 (en)	2003-06-30	Screening method
AU2003242342A1 (en)	2004-02-02	Novel screening method
AU2003303311A1 (en)	2004-08-30	Methods for selecting and screening for trasformants
AU2003298921A1 (en)	2004-06-23	Methods and materials for modulating trpm2

Legal Events

Date	Code	Title	Description
2005-08-04	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase